PLEOPHARMA, INC., 2026-08-10
An SEC Form D private-offering notice from Phoenixville, PA, a $15,000,000 filer-stated offering target in Biotech. Filed 2026-08-10. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage pharmaceutical company developing PP-01, a treatment for cannabis use disorder and cannabis withdrawal.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Aposture Surgical Corp, 2026-08-13, $150K, Philadelphia, PA
- Grace Therapeutics, Inc., 2026-08-11, $10M, Princeton, NJ
- Merlin Biotech, Inc., 2026-08-11, $50K, Doylestown, PA
- Bullseye Biodevices, Inc., 2026-08-10, $1.3M, Hoboken, NJ
- On the Goga, Inc., 2026-08-10, $200K, Philadelphia, PA
- Voyageur Pharmaceuticals Ltd., 2026-08-10, $4.8M, Calgary, AB, Canada
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.